Melipharm Overview
- Founded
- 2011
- Status
- Private
- Latest Deal Type
- Angel
- Investors
- 1
Melipharm General Information
Description
Developer of sterile medical devices intended for the treatment of acute and chronic wounds. The company's sterile medical devices is a natural product which comes from the selection of honey essences whose anti-bacterial and healing properties have been validated by the researchers in the laboratory, enabling doctors to treat acute and chronic wounds based on selected mono floral honey.
Contact Information
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Medical Supplies
Primary Office
- 1 avenue d'Ester
- Cedex
- 87069 Limoges
- France
+33 06 00 00 00 00
Melipharm Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Angel (individual) | 01-Oct-2014 | Completed | Generating Revenue |
Melipharm Patents
Melipharm Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20170072024-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxidase and zinc oxide | Abandoned | 14-May-2014 | 0000000000 | |
| FR-3020948-B1 | Antimicrobial composition | Active | 14-May-2014 | 0000000000 | |
| FR-3020948-A1 | Antimicrobial composition | Granted | 14-May-2014 | 0000000000 | |
| EP-3142687-A1 | Antimicrobial composition comprising a carbohydrate, glucose oxydase and zinc oxide | Pending | 14-May-2014 | 0000000000 | 0 |
| FR-3007291-B1 | Cicatrisante composition and use | Expired - Fee Related | 20-Jun-2013 | A61K35/644 |
Melipharm Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| M Fabien Quero | President |
Melipharm Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Limousin Business Angels | Angel Group | Minority | 000 0000 | 000000 0 |